Recurrent miscarriage: current concepts in diagnosis and treatment

Journal of Reproductive Immunology

Volumn 85, Issue 1, 2010, Pages 25-32

  Toth, Bettina ^a   Jeschke, Udo ^c   Rogenhofer, Nina ^b   Scholz, Christoph ^c   Würfel, Wolfgang ^d   Thaler, Christian J ^b   Makrigiannakis, Antonis ^e  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Kinderwunsch Centrum   (Germany)

^e UNIVERSITY OF CRETE   (Greece)

Author keywords

Current concepts; Recurrent miscarriage; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AUTOANTIBODY; CHORIONIC GONADOTROPIN; GAMMA INTERFERON; GLYCOPROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; HORMONE RECEPTOR; IMMUNOGLOBULIN; LEPTIN; LOW MOLECULAR WEIGHT HEPARIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPID ANTIBODY; PLACEBO; PLACENTA PROTEIN 14; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANAPHYLAXIS; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CELIAC DISEASE; CLINICAL TRIAL; CYTOTROPHOBLAST; DISEASE ASSOCIATION; DRUG FEVER; DRUG INDUCED HEADACHE; ENDOCRINE DISEASE; FERTILIZATION IN VITRO; FLUSHING; HUMAN; IMMUNOSTIMULATION; INFECTION; KIDNEY DYSFUNCTION; LIVE BIRTH; LIVER DISEASE; LYMPHOCYTE TRANSFER; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEMBRANE MICROPARTICLE; MYALGIA; NAUSEA; OFF LABEL DRUG USE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOLOGICAL WELL BEING; RECEPTOR UPREGULATION; RECURRENT ABORTION; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN MANIFESTATION; SOCIAL PSYCHOLOGY; THROMBOPHILIA; TISSUE DIFFERENTIATION; UTERUS MALFORMATION;

EID: 77952092573     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.12.006     Document Type: Review

References (85)

1. Abalovich M., Gutierrez S., Alcaraz G., Maccallini G., Garcia A., Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002, 12:63-68.
2. Ashkar A.A., Di Santo J.P., Croy B.A. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 2000, 192:259-270.
3. Bane A.L., Gillan J.E. Massive perivillous fibrinoid causing recurrent placental failure. BJOG 2003, 110:292-295.
4. Brenner B. Haemostatic changes in pregnancy. Thromb. Res. 2004, 114:409-414.
5. Brenner B. Thrombophilia and pregnancy loss in first intended pregnancy. J. Thromb. Haemost. 2005, 3:2176-2177.
6. Bretelle F., Sabatier F., Desprez D., Camoin L., Grunebaum L., Combes V., D'ercole C., Dignat-George F. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb. Haemost. 2003, 89:486-492.
7. Bulla R., Bossi F., Radillo O., De Seta F., Tedesco F. Placental trophoblast and endothelial cells as target of maternal immune response. Autoimmunity 2003, 36:11-18.
8. Cabrero A., Cubero M., Llaverias G., Alegret M., Sanchez R., Laguna J.C., Vazquez-Carrera M. Leptin down-regulates peroxisome proliferator-activated receptor gamma (PPAR-gamma) mRNA levels in primary human monocyte-derived macrophages. Mol. Cell. Biochem. 2005, 275:173-179.
9. Carp H., Dardik R., Lubetsky A., Salomon O., Eskaraev R., Rosenthal E., Inbal A. Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. Hum. Reprod. 2004, 19:191-195.
10. Carrington B., Sacks G., Regan L. Recurrent miscarriage: pathophysiology and outcome. Curr. Opin. Obstet. Gynecol. 2005, 17:591-597.
11. Christiansen O.B., Pedersen B., Rosgaard A., Husth M. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum. Reprod. 2002, 17:809-816.
12. Christiansen O.B., Steffensen R., Nielsen H.S., Varming K. Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol. Obstet. Invest. 2008, 66:257-267.
13. Clark D.A., Coulam C.B., Daya S., Chaouat G. Unexplained sporadic and recurrent miscarrage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum. Reprod. Update 2001, 7:501-511.
14. Clifford K., Rai R., Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum. Reprod. 1997, 12:387-389.
15. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil. Steril. 2008, 89:505-522.
16. Dell A., Morris H.R., Easton R.L., Panico M., Patankar M., Oehniger S., Koistinen R., Koistinen H., Seppala M., Clark G.F. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J. Biol. Chem. 1995, 270:24116-24126.
17. Dolitzky M., Inbal A., Segal Y., Weiss A., Brenner B., Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil. Steril. 2006, 86:362-366.
18. Ernst P., Bacigalupo A., Ringden O., Ruutu T., Kolb H.J., Lawrinson S., Skacel T. A phase 3, randomized, placebo-controlled trial of filgrastim in patients with haematological malignancies undergoing matched-related allogeneic bone marrow transplantation. Arch. Drug Inf. 2008, 1:89-96.
19. Faridi R.M., Das V., Tripthi G., Talwar S., Parveen F., Agrawal S. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum. Reprod. 2009, 24:1758-1764.
20. Fertl K.I., Bergner A., Beyer R., Klapp B.F., Rauchfuss M. Levels and effects of different forms of anxiety during pregnancy after a prior miscarriage. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009, 142:23-29.
21. Fournier T., Tsatsaris V., Handschuh K., Evain-Brion D. PPARs and the placenta. Placenta 2007, 28:65-76.
22. Franssen M.T., Korevaar J.C., Leschot N.J., Bossuyt P.M., Knegt A.C., Gerssen-Schoorl K.B., Wouters C.H., Hansson K.B., Hochstenbach R., Madan K., Van Der Veen F., Goddijn M. Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ 2005, 331:137-141.
23. Gharesi-Fard B., Zolghadri J., Kamali-Sarvestani E. Effect of leukocyte therapy on tumor necrosis factor-alpha and interferon-gamma production in patients with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2008, 59:242-250.
24. Ghosh K., Shetty S., Vora S., Salvi V. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin. Clin. Appl. Thromb. Hemost. 2008, 14:174-179.
25. Gonzalez-Quintero V.H., Smarkusky L.P., Jimenez J.J., Mauro L.M., Jy W., Hortsman L.L., O'sullivan M.J., Ahn Y.S. Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am. J. Obstet. Gynecol. 2004, 191:1418-1424.
26. Henson M.C., Swan K.F., O'neil J.S. Expression of placental leptin and leptin receptor transcripts in early pregnancy and at term. Obstet. Gynecol. 1998, 92:1020-1028.
27. Hiby S.E., Regan L., Lo W., Farrell L., Carrington M., Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 2008, 23:972-976.
28. Hirahara F., Andoh N., Sawai K., Hirabuki T., Uemura T., Minaguchi H. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil. Steril. 1998, 70:246-252.
29. Homburg R. Pregnancy complications in PCOS. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20:281-292.
30. Homburg R. Polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 2008, 22(2):261-274. Epub 2007 Sep 5. Review.
31. Homer H.A., Li T.C., Cooke I.D. The septate uterus: a review of management and reproductive outcome. Fertil. Steril. 2000, 73:1-14.
32. Jakubowicz D.J., Iuorno M.J., Jakubowicz S., Roberts K.A., Nestler J.E. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2002, 87:524-529.
33. Jauniaux E., Farquharson R.G., Christiansen O.B., Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum. Reprod. 2006, 21:2216-2222.
34. Jeschke U., Briese V., Richter D., Kunkel S. Stimulation trials of trophoblast cells in vitro using PP14. Z. Geburtshilfe Neonatol. 1996, 200:199-201.
35. Jeschke U., Briese V., Richter D., Kunkel S., Walzel H., Friese K. Neue Ergebnisse zur hCG-regulation in der plazenta. Geburtshilfe Frauenheilkd 1997, 57:681-684.
36. Jeschke U., Karsten U., Reimer T., Richter D.U., Bergemann C., Briese V., Mylonas I., Friese K. Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A. J. Perinat. Med. 2005, 33:212-218.
37. Jeschke U., Richter D.U., Walzel H., Bergemann C., Mylonas I., Sharma S., Keil C., Briese V., Friese K. Stimulation of hCG and inhibition of hPL in isolated human trophoblast cells in vitro by glycodelin A. Arch. Gynecol. Obstet. 2003, 268:162-167.
38. Jeschke U., Stahn R., Goletz C., Wang X., Briese V., Friese K. hCG in trophoblast tumour cells of the cell line Jeg3 and hCG isolated from amniotic fluid and serum of pregnant women carry oligosaccharides of the sialyl Lewis X and sialyl Lewis a type. Anticancer Res. 2003, 23:1087-1092.
39. Lappas M., Permezel M., Rice G.E. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated kinase 1/2. Endocrinology 2005, 146:3334-3342.
40. Laskin C.A., Spitzer K.A., Clark C.A., Crowther M.R., Ginsberg J.S., Hawker G.A., Kingdom J.C., Barrett J., Gent M. Low molecular Weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J. Rheumatol. 2009, 36(2):279-287.
41. Laude I., Rongieres-Bertrand C., Boyer-Neumann C., Wolf M., Mairovitz V., Hugel B., Freyssinet J.M., Frydman R., Meyer D., Eschwege V. Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb. Haemost. 2001, 85:18-21.
42. Laurino M.Y., Bennett R.L., Saraiya D.S., Baumeister L., Doyle D.L., Leppig K., Pettersen B., Resta R., Shields L., Uhrich S., Varga E.A., Raskind W.H. Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors. J. Genet. Couns. 2005, 14:165-181.
43. Leong H., Stachnik J., Bonk M.E., Matuszewski K.A. Unlabeled uses of intravenous immune globulin. Am. J. Health Syst. Pharm. 2008, 65:1815-1824.
44. Li T.C., Makris M., Tomsu M., Tuckerman E., Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum. Reprod. Update 2002, 8:463-481.
45. Ludvigsson J.F., Montgomery S.M., Ekbom A. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology 2005, 129:454-463.
46. Meirhaeghe A., Fajas L., Helbecque N., Cottel D., Lebel P., Dallongeville J., Deeb S., Auwerx J., Amouyel P. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum. Mol. Genet. 1998, 7:435-440.
47. Meisel C., Schefold J.C., Pschowski R., Baumann T., Hetzger K., Gregor J., Weber-Carstens S., Hasper D., Keh D., Zuckermann H., Reinke P., Volk H.D. GM-CSF to reverse sepsis-associated immunosuppression: a double-blind randomized placebo-controlled multicenter trial. Am. J. Respir. Crit. Care Med. 2009, 180(7):585-586.
48. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H., Pg D.E.G., Koike T., Meroni P.L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P.G., Krilis S.A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006, 4:295-306.
49. Moffett A., Hiby S. Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum. Reprod. 2009, 24:2048-2049.
50. Moffett A., Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006, 6:584-594.
51. Muy-Rivera M., Ning Y., Frederic I.O., Vadachkoria S., Luthy D.A., Williams M.A. Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk. Physiol. Res. 2005, 54:167-174.
52. Nonaka T., Takakuwa K., Ooki I., Akashi M., Yokoo T., Kikuchi A., Tanaka K. Results of immunotherapy for patients with unexplained primary recurrent abortions-prospective non-randomized cohort study. Am. J. Reprod. Immunol. 2007, 58:530-536.
53. Pham T., Claudepierre P., Deprez X., Fautrel B., Goupille P., Hilliquin P., Masson C., Morel J., Puechal X., Saraux A., Schaeverbeke T., Mariette X., Sibilia J. Anti-TNF alpha therapy and safety monitoring. clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Francaise de Rhumatologie, SFR). Joint Bone Spine 2005, 72(1):S1-58.
54. Porcu G., Cravello L., D'ercole C., Cohen D., Roger V., De Montgolfier R., Blanc B. Hysteroscopic metroplasty for septate uterus and repetitive abortions: reproductive outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2000, 88:81-84.
55. Rai R., Regan L. Recurrent miscarriage. Lancet 2006, 368:601-611.
56. Rai R., Tuddenham E., Backos M., Jivraj S., El'gaddal S., Choy S., Cork B., Regan L. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum. Reprod. 2003, 18:2540-2543.
57. Reimer T., Koczan D., Briese V., Friese K., Richter D., Thiesen H.J., Jeschke U. Absolute quantification of human chorionic gonadotropin-beta mRNA with TaqMan detection. 4. Mol. Biotechnol. 2000, 14:47-57.
58. Roberts D., Schwartz R.S. Clotting and hemorrhage in the placenta-a delicate balance. N. Engl. J. Med. 2002, 347:57-59.
59. Rodger M.A., Paidas M., Mclintock C., Middeldorp S., Kahn S., Martinelli I., Hague W., Rosene Montella K., Greer I. Inherited thrombophilia and pregnancy complications revisited. Obstet. Gynecol. 2008, 112:320-324.
60. Salim R., Miel J., Savvas M., Lee C., Jurkovic D. A comparative study of glycodelin concentrations in uterine flushings in women with subseptate uteri, history of unexplained recurrent miscarriage and healthy controls. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007, 133:76-80.
61. Salim R., Regan L., Woelfer B., Backos M., Jurkovic D. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum. Reprod. 2003, 18:162-166.
62. Scarpellini F., Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum. Reprod. 2009, 24(11):2703-2708. Epub 2009 Jul 17.
63. Scholz C., Toth B., Brunnhuber R., Rampf E., Weissenbacher T., Santoso L., Friese K., Jeschke U. Glycodelin A induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro. Am. J. Reprod. Immunol. 2008, 60:501-512.
64. Scott J.R. Immunotherapy for recurrent miscarriage. Cochrane Database Syst. Rev. 2003, CD000112.
65. Stahn R., Goletz S., Stahn R., Wilmanowski R., Wang X., Briese V., Friese K., Jeschke U. Human chorionic gonadotropin (hCG) as inhibitior of E-selectin-mediated cell adhesion. Anticancer Res. 2005, 25:1811-1816.
66. Stern J.J., Dorfmann A.D., Gutierrez-Najar A.J., Cerrillo M., Coulam C.B. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil. Steril. 1996, 65:250-253.
67. Stray-Pedersen B., Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am. J. Obstet. Gynecol. 1984, 148:140-146.
68. Stumvoll M., Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 2002, 51:2341-2347.
69. Sugimura M., Kobayashi T., Shu F., Kanayama N., Terao T. Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta 1999, 20:555-560.
70. Sugiura-Ogasawara M., Furukawa T.A., Nakano Y., Hori S., Aoki K., Kitamura T. Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum. Reprod. 2002, 17:2580-2584.
71. Tarrade A., Lai Kuen R., Malassine A., Tricottet V., Blain P., Vidaud M., Evain-Brion D. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab. Invest. 2001, 81:1199-1211.
72. Toth B. Microparticles and female issues. Hamostaseologie 2009, 29:46-50.
73. Toth B., Bastug M., Mylonas I., Scholz C., Makovitzky J., Kunze S., Thaler C., Friese K., Jeschke U. Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage. Acta Histochem. 2009, 111(4):372-378. Epub 2009 Apr 1.
74. Toth B., Bastug M., Mylonas I., Scholz C., Makovitzky J., Kunze S., Thaler C., Friese K., Jeschke U. Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage. Acta Histochem. 2009, 111:372-378.
75. Toth B., Bastug M., Scholz C., Arck P., Schulze S., Kunze S., Friese K., Jeschke U. Leptin and peroxisome proliferator-activated receptors: impact on normal and disturbed first trimester human pregnancy. Histol. Histopathol. 2008, 23:1465-1475.
76. Toth B., Hornung D., Scholz C., Djalali S., Friese K., Jeschke U. Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am. J. Reprod. Immunol. 2007, 58:289-310.
77. Toth B., Nieuwland R., Kern M., Rogenhofer N., Berkmans R., Rank A., Lohse P., Friese K., Thaler C.J. Systemic changes in haemostatic balance are not associated with increased levels of circulating microparticles in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2008, 59:159-166.
78. Toth B., Roth K., Kunert-Keil C., Scholz C., Schulze S., Mylonas I., Friese K., Jeschke U. Glycodelin protein and mRNA is downregulated in human first trimester abortion and partially upregulated in mole pregnancy. J. Histochem. Cytochem. 2008, 56:477-485.
79. Tursi A., Giorgetti G., Brandimarte G., Elisei W. Effect of gluten-free diet on pregnancy outcome in celiac disease patients with recurrent miscarriages. Dig. Dis. Sci. 2008, 53:2925-2928.
80. Van Den Heuvel M.J., Peralta C.G., Hatta k., Han V.K., Clark D.A. Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am. J. Reprod. Immunol. 2007, 58:447-459.
81. Vanwijk M.J., Vanbavel E., Sturk A., Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc. Res. 2003, 59:277-287.
82. Whiteside T.L. Cytokine measurements and interpretation of cytokine assays in human disease. J. Clin. Immunol. 1994, 14:327-339.
83. Winger E.E., Reed J.L. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am. J. Reprod. Immunol. 2008, 60:8-16.
84. Winger E.E., Reed J.L., Ashoush S., Ahuja S., El-Toukhy T., Taranissi M. Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am. J. Reprod. Immunol. 2009, 61:113-120.
85. Yang H., Qiu L., Di W., Zhao A., Chen G., Hu K., Lin Q. Proportional change of CD4+ CD25+ regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. Fertil. Steril. 2009, 92:301-305.